Kevin R Keene

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Active immunotherapy aimed at the stimulation of tumor-specific T cells has established itself within the clinic as a therapeutic option to treat cancer. One strategy is the use of so-called peptides that mimic genuine T-cell epitopes as vaccines to activate tumor-specific T cells. In various clinical trials, different types of vaccines, adjuvants and other(More)
  • 1